Stage-four cancer survivor hails rehabilitation trial
A man who is in remission from stage-four prostate cancer has said he is "a different person" after taking part in a 12-week rehabilitation trial.
A 66-year-old man from Kanturk, Co Cork, John Bradley, has hailed a 12-week rehabilitation trial for stage-four prostate cancer survivors. The LIAM Mc Trial, launched in 2022 and developed by Cancer Research at UCC, provided participants with specialist physiotherapy, nursing, dietetic advice, and psychological support. Bradley, who was diagnosed with stage-four prostate cancer in 2022, underwent 39 sessions of radiotherapy and is now in remission.
He noted that the therapy had severe side effects, including lethargy, insomnia, and concentration difficulties. After the trial, Bradley's muscle mass increased by 40%, and he felt like a "different person," expressing a renewed sense of well-being. The trial, funded by the Irish Cancer Society, saw 56 participants, with researchers noting an overwhelmingly positive response.
With renewed funding of €100,000, researchers will delve deeper into the trial's findings, explore changes in participants' muscle mass, and gather longer-term follow-up data. The ultimate goal is to integrate supportive rehabilitation into routine cancer aftercare in Ireland. Bradley now enjoys swimming and gym sessions, hoping his experience will encourage others to participate in similar trials.
Written by urgent.news from RTE News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
